Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure

Blake Gregory, Anne M. Larson, Joan Reisch, William M. Lee

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Background: Acetaminophen is a dose-dependent toxin. Prognosis in severe acute liver injury is related presumably in part to the dose ingested. We sought to assess the value of acetaminophen dosing information in patients with acute liver failure (ALF) due to acetaminophen toxicity to determine the role of dose as a prognostic indicator. Methods: Prospective data from 113 patients with ALF having singletime- point ingestions of acetaminophen were analyzed. Multivariate and x2 tests were used to determine the relationship of dose to clinical outcome. We also used the Mann-Whitney U test to compare prognosis and survival in ALF with acetaminophen dose ingested. Results: Multivariate and x2 analyses failed to show any relationship between acetaminophen dose and spontaneous survival. A separate analysis showed no correlation between acetaminophen dose and clinical prognostic indicators. Conclusions: Dose of acetaminophen ingested did not seem to play a role in prognosis. The most important prognostic factor was coma grade on admission to study. Acetaminophen dosing information is not always obtainable. When it is, it adds little to the clinical assessment. Severity of encephalopathy is a more reliable indicator of prognosis in these critically ill patients.

Original languageEnglish (US)
Pages (from-to)707-710
Number of pages4
JournalJournal of Investigative Medicine
Issue number5
StatePublished - Jun 2010


  • Acetaminophen
  • Acute liver failure
  • N-acetylcysteine

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure'. Together they form a unique fingerprint.

Cite this